![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 5
2023
Alter, Peter 
ORCID: https://orcid.org/0000-0002-2115-1743; Stoleriu, Cosmina; Kahnert, Kathrin ORCID: https://orcid.org/0000-0001-9633-3368; Henke, Markus; Bals, Robert; Trudzinski, Franziska ORCID: https://orcid.org/0000-0002-0980-7586; Watz, Henrik; Speicher, Tim; Söhler, Sandra ORCID: https://orcid.org/0000-0001-5851-1872; Welte, Tobias ORCID: https://orcid.org/0000-0002-9947-7356; Rabe, Klaus ORCID: https://orcid.org/0000-0002-7020-1401; Wouters, Emiel; Vogelmeier, Claus und Jörres, Rudolf A. ORCID: https://orcid.org/0000-0002-9782-1117
(2023):
Characteristics of Current Smokers versus Former Smokers with COPD and Their Associations with Smoking Cessation Within 4.5 Years: Results from COSYCONET.
In: International Journal of Chronic Obstructive Pulmonary Disease, Bd. 18: S. 2911-2923
ORCID: https://orcid.org/0000-0002-2115-1743; Stoleriu, Cosmina; Kahnert, Kathrin ORCID: https://orcid.org/0000-0001-9633-3368; Henke, Markus; Bals, Robert; Trudzinski, Franziska ORCID: https://orcid.org/0000-0002-0980-7586; Watz, Henrik; Speicher, Tim; Söhler, Sandra ORCID: https://orcid.org/0000-0001-5851-1872; Welte, Tobias ORCID: https://orcid.org/0000-0002-9947-7356; Rabe, Klaus ORCID: https://orcid.org/0000-0002-7020-1401; Wouters, Emiel; Vogelmeier, Claus und Jörres, Rudolf A. ORCID: https://orcid.org/0000-0002-9782-1117
(2023):
Characteristics of Current Smokers versus Former Smokers with COPD and Their Associations with Smoking Cessation Within 4.5 Years: Results from COSYCONET.
In: International Journal of Chronic Obstructive Pulmonary Disease, Bd. 18: S. 2911-2923
2022
Kahnert, Kathrin; Fischer, Carolina; Alter, Peter; Trudzinski, Franziska; Welte, Tobias; Behr, Jürgen; Herth, Felix; Kauczor, Hans-Ulrich; Bals, Robert; Watz, Henrik; Rabe, Klaus; Söhler, Sandra; Kokot, Inge; Vogelmeier, Claus und Jörres, Rudolf A. ORCID: https://orcid.org/0000-0002-9782-1117
(2022):
Was haben wir aus der deutschen COPD-Kohorte COSYCONET gelernt und wie geht es weiter?
In: Pneumologie, Bd. 77, Nr. 2: S. 81-93
ORCID: https://orcid.org/0000-0002-9782-1117
(2022):
Was haben wir aus der deutschen COPD-Kohorte COSYCONET gelernt und wie geht es weiter?
In: Pneumologie, Bd. 77, Nr. 2: S. 81-93
2021
Presotto, Maria Ada; Jörres, Rudolf A. ORCID: https://orcid.org/0000-0002-9782-1117; Gesierich, Wolfgang; Bullwinkel, Jörn; Rabe, Klaus; Schultz, Konrad; Kaestner, Franziska; Harzheim, Dominik; Kreuter, Michael; Herth, Felix J. F. und Trudzinski, Franziska
(2021):
Late Breaking Abstract - COVID-19 risk perception and vaccine willingness among healthcare workers in specialized respiratory clinics in Germany.
ERS International Congress 2021, Virtual, September 5 to 8, 2021.
European Respiratory Journal.
Bd. 58, Nr. Suppl. 65, PA3891
Sheffield: European Respiratory Society.
ORCID: https://orcid.org/0000-0002-9782-1117; Gesierich, Wolfgang; Bullwinkel, Jörn; Rabe, Klaus; Schultz, Konrad; Kaestner, Franziska; Harzheim, Dominik; Kreuter, Michael; Herth, Felix J. F. und Trudzinski, Franziska
(2021):
Late Breaking Abstract - COVID-19 risk perception and vaccine willingness among healthcare workers in specialized respiratory clinics in Germany.
ERS International Congress 2021, Virtual, September 5 to 8, 2021.
European Respiratory Journal.
Bd. 58, Nr. Suppl. 65, PA3891
Sheffield: European Respiratory Society.
2018
Pech, Martin; Weckmann, Markus; König, Inke R.; Franke, Andre; Heinsen, Femke-Anouska; Oliver, Brian; Ricklefs, Isabel; Fuchs, Oliver; Rabe, Klaus; Hansen, Gesine; Mutius, Erika und Kopp, Matthias
(2018):
Rhinovirus infections change DNA methylation and mRNA expression in children with asthma.
In: PLOS One 13(11), e0205275 [PDF, 1MB]
In: PLOS One 13(11), e0205275 [PDF, 1MB]
2017
Behr, Jürgen; Neuser, Petra; Prasse, Antje; Kreuter, Michael; Rabe, Klaus; Schade-Brittinger, Carmen; Wagner, Jasmin und Günther, Andreas
(2017):
Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) - a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial.
In: BMC Pulmonary Medicine
17:122
[PDF, 358kB]